Abstract. Additional strategies are needed to prevent and treat tuberculosis (TB). Although vitamin D may have antimycobacterial effects, it is unknown whether low vitamin D status confers a risk for active TB in African children. This case-control study assessed serum 25-hydroxyvitamin D (25(OH)D) concentration in children with and without active TB in Gaborone, Botswana. A total of 80 children under 2 years old with and without active TB, seen at hospitals and clinics in the greater Gaborone area between September 2010 and November 2012, were enrolled. Of these, 39 cases did not differ from the 41 controls in median 25(OH)D levels (P = 0.84). The 25(OH)D was < 20 ng/mL in 8/39 (21%) cases and 7/41 (17%) controls (P = 0.69, χ 2 ). Univariate analyses of subject clinical characteristics (other than 25(OH) D levels) showed that any degree of weight loss was associated with a diagnosis of TB (P = 0.047). Other clinical characteristics, including age (P = 0.08) or weight below third percentile (P = 0.58), showed no association with TB. There was no significant difference in vitamin D status between children under 2 years old with and without active TB. Lower vitamin D status did not appear to be a risk factor for TB in this small Gaborone cohort.
INTRODUCTION
The burden of tuberculosis (TB) in Botswana is among the highest in the world. In 2012, the incidence of TB was 408/ 100,000, and the TB and human immunodeficiency virus (HIV) coinfection rate was 62%. 1 In an immunocompetent adult population, after TB exposure, there is a lifetime conversion risk of 10% from latent TB to active TB. However, in HIV-infected adult patients, this risk increases to 10% per year. 1 In children, this risk is even higher and increases to as much as 50% in infants exposed to an adult with a history of smear-positive TB. 2 The precise burden of childhood TB in Botswana is unknown. In a tertiary hospital-based autopsy study before the widespread rollout of antiretrovirals, 12.5% of HIV-seropositive children were found to have pulmonary TB. 3 In 2012, the Botswana National TB Program reported that childhood TB cases, being those under 15 years old, accounted for 10% of the national TB caseload. 4 Vitamin D may have unique antimicrobial effects on TB. 5 In adult TB patients receiving TB treatment, supplementation with vitamin D is associated with increased rates of smear conversion from positive to negative for acid-fast bacilli. 6 A proposed mechanism is that vitamin D enhances macrophage function thereby augmenting human immunity to mycobacteria. 7 In addition, vitamin D deficiency is suggested to be associated with mycobacterial diseases. 8 Although vitamin D supplementation may decrease susceptibility to active TB, there are minimal data exploring vitamin D status in pediatric patients living in Africa, a TB-endemic setting. 6 Our objective was to assess serum 25-hydroxyvitamin D (25(OH)D) status in children with and without active TB in Gaborone, Botswana, a high-burden TB setting in southern Africa.
MATEIRALS AND METHODS
Setting. This prospective case-control study evaluated serum 25(OH)D concentrations of infants and toddlers with and without TB in hospitals and clinics in the greater Gaborone area between September 2010 and November 2012.
Study population. Children in Botswana aged 0 to 2 years old, with and without active TB, admitted to the pediatric ward at Princess Marina Hospital in Gaborone, Bamalete Lutheran Hospital in Ramotswa, Scottish Livingstone Hospital in Molepolole, and Deborah Retief Memorial Hospital in Mochudi, as well as outpatients seen at the Gaborone city clinics were eligible for enrollment.
Eligibility criteria and study definitions. Cases were defined as patients diagnosed by a pediatrician as having active TB at the time of enrollment. Controls were defined as patients without active TB. Cases and controls were selected from patients admitted to one of the selected hospitals or visiting one of the Gaborone city clinics. Neither cases nor controls had a history of a previous episode of active TB before enrollment. Although study enrollment commenced before these criteria had been published, we retrospectively applied the consensus TB diagnostic definitions as described by Graham and others 9 to classify enrolled TB cases. The diagnostic level for each TB case was at least at the level of "probable" for cases. This included cases diagnosed by chest X-ray and symptoms as well as those diagnosed by microbiological confirmation. 10 Controls had to meet criteria for "not TB," lacking clinical, radiographic, and laboratory evidence of TB. Microbiological confirmation included smear or culture of gastric aspirate or sputum induction samples for intrathoracic cases, and biopsy for extrathoracic diagnoses. The cases recruited were naive to a complete course of antituberculous therapy (ATT). This was defined as use of ATT for 21 days or less , London, United Kingdom). The coefficients for interassay variation for low and high controls were 8% and 6%, respectively, and for intraassay variation for low and high controls were 5% and 3%, respectively.
Analysis. The overall 25(OH)D concentrations were compared between groups using the Wilcoxon rank-sum test. The outcome was being a TB case or not (control). The exposure was explored in two ways: as a continuous variable (serum 25(OH)D) and as a dichotomous one (25(OH)D deficient or not). Statistical significance was defined as P < 0.05. A sample size of 80 participants was chosen with a goal of enrolling 40 cases and 40 controls. This sample size was not based on a power calculation as there were no prior studies on this topic in this or similar populations to inform such a calculation. This sample size was chosen to assess the variability of 25(OH)D in individuals with and without TB and to potentially inform the design of a larger study.
Ethics. This study was reviewed and approved by the institutional review boards of the Botswana Ministry of Health, Princess Marina Hospital, and the University of Pennsylvania. Written informed consent was obtained from a legal guardian of each subject before study enrollment.
RESULTS
A total of 39 cases and 41 controls were enrolled, and groups did not differ when comparing demographic characteristics ( Table 1 ). The groups were not evenly matched in number as one control's TB workup was positive, changing this subject's status from control to case. Among cases with active TB, the mean age was 10.8 months, 41% were male, and six (15%) were HIV infected. Among the control group, the mean age was 8.5 months, 54% were male, and seven (18%) were HIV infected. Although a higher proportion (49% versus 27%) of TB cases as compared with controls were older than 12 months, there was no significant difference between the mean age of the two groups.
The median 25(OH)D level did not differ between cases (32.2 ng/mL) and controls (30.9 ng/mL; Table 2 ). A total of 15 children were vitamin D deficient with no difference in the proportion that was deficient in cases as compared with controls.
Univariate analyses of patient clinical characteristics in addition to vitamin D levels revealed that as age increased, the risk of TB increased as well (P = 0.08). However, of the factors explored (weight loss, HIV status, parental education, formula feeding, and sunlight exposure) only a history of any weight loss experienced by a patient was a significant predictor of TB (P = 0.047).
DISCUSSION
We evaluated vitamin D status in infants and toddlers with and without TB in an African setting. In this hospital and HAART = highly active antiretroviral therapy; HIV = human immunodeficiency virus; IQR = interquartile range; NA = not applicable; TB = tuberculosis. *By rank-sum test. †By χ 2 test. ‡Data are for 38 subjects as "days on TB treatment" was not captured in one subject.
clinic-based cohort, we found no difference in serum 25(OH) D between those with TB and those without. Similarly, although 18.8% of the overall cohort were vitamin D deficient (< 20 ng/mL), the proportion of those who were deficient did not differ between groups.
The vitamin D status of Botswana's children has not been described previously. However, a recent study conducted in Botswana evaluated maternal vitamin D status among HIVinfected, antiretroviral-naive women, with CD4 counts ≥ 200 cells/mm 3 and no acquired immunodeficiency syndrome (AIDS)-defining illnesses. 11 Although vitamin D insufficiency (defined as < 32 ng/mL) was common (32% of women), there was no association with morbidity, mortality, or growth delay in the study subjects' children.
11 By comparison, a 2011 South African study conducted among healthy 10-year olds that were part of a longitudinal Birth to Twenty cohort found a vitamin D deficiency (defined as < 20 ng/mL by this study) prevalence of 7%, 12 whereas a Tanzanian study in 6-monthold HIV-exposed uninfected infants found a prevalence of 34.6%. 13 The proportion of 25(OH)D-deficient children in our study falls between these two studies.
There was no difference in serum 25(OH)D between children with TB and those without. This finding is consistent with recently conducted pediatric studies in Pune, India, and Westmead, Australia. In Pune, Jubulis and others explored modifiable risk factors for TB in children of age five or younger. They found a high prevalence of vitamin D deficiency (52%) among the 178 children in the study; however, there was no association between low 25(OH)D concentrations and TB infection.
14 Similarly, a study conducted at a refugee clinic in Westmead, Australia, found a high incidence of vitamin D deficiency (56%) among children but without a correlation with TB infection. 15 In addition, our findings are in keeping with a similar study exploring 25(OH)D concentrations in HIV-infected adults with and without TB in Botswana. 16 There were several limitations to this study. First, our study population is modest and may not be adequately powered to detect small differences between groups. However, a comparison of the median 25(OH)D between groups shows that the values are very similar suggesting that no difference would have been found even with a larger sample size. Moreover, given that the study was conducted in and around Gaborone, which is an urban setting, our results may not be generalizable to a national or regional level. Third, our cross-sectional design assessed 25(OH)D concentrations at one point in time, that is, at diagnosis in cases and at admission or clinic visit in controls. Thus, we were not able to assess whether cases had a low 25(OH)D in the weeks or months before they were diagnosed with TB. Furthermore, diagnostic criteria for TB were applied retrospectively making it vulnerable to all limitations inherent to retrospective design.
CONCLUSIONS
We found no significant difference in vitamin D status between infants and toddlers with and without active TB. Our data suggest that low vitamin D status may not be a risk factor for TB in this small Gaborone cohort. Further studies are necessary to evaluate if there is a role for vitamin D in pediatric TB. 
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